Most Read Articles
13 Sep 2020
Regardless of birth weight, being obese at preschool age is associated with a greater risk of elevated blood pressure during early childhood, a recent China study has found. A longer duration of breastfeeding appears to help mitigate such a risk.
Jairia Dela Cruz, 4 days ago
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
06 Sep 2020
Type 2 diabetes mellitus patients taking proton pump inhibitors (PPIs) are at a higher risk of sustaining hip fractures, a recent study has found.
6 days ago
Osteoarthritis (OA) is the most common condition affecting the joints. Dr Lee Eu Jin, an Orthopaedic Surgeon from Liberty Orthopaedic Clinic at Mount Elizabeth Medical Centre, Singapore, shares his insights with Pearl Toh on how to manage OA in the primary care setting.


Low-dose indacaterol/mometasone improves FEV1 in adolescents, adults with asthma

Elaine Soliven
11 Oct 2019
Dr Peter Andrea

The use of low-dose indacaterol acetate/mometasone furoate (IND/MF), a long-acting β2-agonist/inhaled corticosteroid (LABA/ICS) combination, significantly improves trough FEV1* in symptomatic patients with poorly controlled asthma, according to the QUARTZ** study presented at ERS 2019.

This phase III, multicentre, double-blind, double-dummy, parallel-group trial involved 64 adolescents and 738 adults (aged ≥12 and ≤75 years) with inadequately controlled asthma who were taking low-dose ICS, with or without LABA, for ≥1 month. They were randomized 1:1 to receive either IND/MF (150/80 μg; n=398) or MF alone (200 μg; n=404) once daily for 12 weeks. [ERS 2019, abstract RCT3780]

At 12 weeks, patients treated with IND/MF had a significantly greater improvement from baseline in trough FEV1 compared with MF alone (0.234 vs 0.051 L; mean difference, 0.182 L, 95 percent confidence interval [CI], 0.148–0.217; p<0.001).

Patients on IND/MF also reported significant improvement from baseline in asthma control, as shown by Asthma Control Questionnaire (ACQ)-7 score, than those on MF alone at 12 weeks (-0.947 vs -0.730; mean difference, -0.218, 95 percent CI, -0.293 to -0.143; p<0.001).

In a responder analysis, more patients on IND/MF achieved an improvement of ≥0.5 units in the ACQ-7 score after 12 weeks compared with those on MF alone (74.7 percent vs 64.9 percent; odds ratio, 1.69, 95 percent CI, 1.23–2.33).

Adverse events (AEs) occurred at a lower rate in the IND/MF arm (32.3 percent vs 38.3 percent), while serious AEs occurred at a comparable rate between the IND/MF and MF arms (1.3 percent vs 1.8 percent).

“GINA*** 2019 recommends the addition of LABA to ICS monotherapy as the maintenance controller therapy in patients with inadequately controlled asthma. The combination helps in achieving asthma control [in terms of ACQ-7 score] by reducing symptoms and improving lung function [in terms of trough FEV1 score] in these patients,” said Dr Peter Andrea from Novartis Pharmaceuticals Corporation at East Hanover in New Jersey, US.

“To our knowledge, this is the first study to compare a low-dose ICS/LABA fixed-dose combination once-daily to low-dose ICS monotherapy in adult and adolescent patients with inadequately controlled asthma, … [and] this study provided evidence for benefits across a range of lung function and symptomatic endpoints,” Andrea said.

“Overall, results support the use of IND/MF 150/80 µg once-daily as a potential treatment in adult and adolescent patients with asthma inadequately controlled on low-dose ICS (+/- controller),” he concluded.

 

*FEV1: Forced expiratory volume in 1 second

**QUARTZ: Study of QMF149 (150/80 µg) compared with MF Twisthaler® (200 µg) in patients with asthma

***GINA: Global Initiative for Asthma
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
13 Sep 2020
Regardless of birth weight, being obese at preschool age is associated with a greater risk of elevated blood pressure during early childhood, a recent China study has found. A longer duration of breastfeeding appears to help mitigate such a risk.
Jairia Dela Cruz, 4 days ago
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
06 Sep 2020
Type 2 diabetes mellitus patients taking proton pump inhibitors (PPIs) are at a higher risk of sustaining hip fractures, a recent study has found.
6 days ago
Osteoarthritis (OA) is the most common condition affecting the joints. Dr Lee Eu Jin, an Orthopaedic Surgeon from Liberty Orthopaedic Clinic at Mount Elizabeth Medical Centre, Singapore, shares his insights with Pearl Toh on how to manage OA in the primary care setting.